Thus, knocking out the β2-microglobulin in the tumor cells would eliminate TSPY-peptide MHC-I complex formation and presentation on the cell surface, thereby abolishing such CD8+ cytotoxic T cell attacks on these B2m negative but TSPY-positive tumor cells, which were then grew to larger tumor foci. The gene discussed is B2M; the disease is neoplasm.